|
|
| |
|
|
|
|
|
|
12343 |
Á¦ÁÖ |
2022³â ´ëÇѼÒȱ⳻½Ã°æÇÐȸ Á¦ÁÖÁöȸ Á¦9ȸ ¿¬¼ö°Á : 2022-05-07 |
0 |
289 |
2022-04-13 |
|
|
|
12342 |
¼¿ï |
Á¦35ȸ ´ëÇÑ¿Ü°ú´ë»ç¿µ¾çÇÐȸ Çмú´ëȸ ¹× 2022 ±¹Á¦½ÉÆ÷Áö¾ö(1ÀÏÂ÷) : 2022-05-06 |
0 |
179 |
2022-04-13 |
|
|
|
12341 |
¼¿ï |
2022 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2022-05-06 |
0 |
154 |
2022-04-13 |
|
|
|
12340 |
´ë±¸ |
´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ´ë±¸°æºÏÁöȸ Çмúȸ : 2022-05-03 |
0 |
179 |
2022-04-13 |
|
|
|
12339 |
°¿ø |
2022³â Ãáõ½ÃÀÇ»çȸ Ãá°è ¿¬¼ö°ÁÂ(´ç´¢º´, ȯÀÚ¾ÈÀü °ü·Ã ±³À°) : 2022-05-02 |
0 |
160 |
2022-04-13 |
|
|
|
12338 |
¼¿ï |
2022³â ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ Á¦16ȸ Ãá°èÇмú´ëȸ : 2022-05-01 |
0 |
239 |
2022-04-13 |
|
|
|
12337 |
¼¿ï |
2022³â ´ëÇѺ´¿øÀåÇùÀÇȸ Ãá°èÇмú´ëȸ : 2022-05-01 |
0 |
453 |
2022-04-13 |
|
|
|
12336 |
¼¿ï |
Çѱ¹¿©ÀÚÀÇ»çȸ The application of JAK inhibitors in dermatology : 2022-04-30 |
0 |
171 |
2022-04-13 |
|
|
|
12335 |
°¿ø |
2022³â ´ëÇѼÒȱ⳻½Ã°æÇÐȸ °¿øÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2022-04-30 |
0 |
190 |
2022-04-13 |
|
|
|
12334 |
°æºÏ |
´ëÇÑ»êºÎÀΰúÇÐȸ Á¦66Â÷ »êºÎÀΰú ¿¬¼ö°Á ¹× ¹ßÀü¸ðÀÓ(2ÀÏÂ÷) : 2022-04-30 |
0 |
163 |
2022-04-13 |
|
|
|
12333 |
¼¿ï |
(¿Â¶óÀÎ) ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 4¿ù ¿ù·ÊÁý´ãȸ : 2022-04-30 |
0 |
178 |
2022-04-13 |
|
|
|
12332 |
¼¿ï |
´ëÇÑ°ñÀýÇÐȸ Á¦48Â÷ Çмú´ëȸ(2ÀÏÂ÷) : 2022-04-30 |
0 |
167 |
2022-04-13 |
|
|
|
12331 |
¼¿ï |
´ëÇѽÉÀåÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(2ÀÏÂ÷) : 2022-04-30 |
0 |
172 |
2022-04-13 |
|
|
|
12330 |
¼¿ï |
´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó 1ºÎ(1ÀÏÂ÷) : 2022-04-30 |
0 |
138 |
2022-04-13 |
|
|
|
12329 |
¼¿ï |
´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó 2ºÎ(2ÀÏÂ÷) : 2022-04-30 |
0 |
139 |
2022-04-13 |
|
|